Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Takeda to Develop Zika Virus Vaccine With US Subsidies

Filed Under: Innovation, Pharma Tagged With: , , , ,

Takeda Pharmaceutical Co. Ltd. (TYO:4502) announced on Sep. 2 that it plans to develop a vaccine for the Zika virus…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Coronavirus Report – Part 13: Japanese Companies Start to Develop Vaccines, Treatments
Coronavirus Report – Part 13: Japanese Companies Start to…
Coronavirus Report – Part 77: Japan’s Pharmaceutical Companies Move in Quick Order to Treat Infection
Coronavirus Report – Part 77: Japan’s Pharmaceutical…
Coronavirus Report – Part 58: Clinical Trials Begin for Slew of Potential Vaccines
Coronavirus Report – Part 58: Clinical Trials Begin for Slew…
Column: COVID-19 Brings Major Changes to Vaccine Development
Column: COVID-19 Brings Major Changes to Vaccine Development
Just How Effective Will Vaccines Be in Combating the COVID-19 Pandemic?
Just How Effective Will Vaccines Be in Combating the…
Coronavirus Report – Part 27: Pandemic Sees Clinical Trials for New Drugs Suspended, Postponed
Coronavirus Report – Part 27: Pandemic Sees Clinical Trials…